Cargando…

Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

The use of natural products in dermatology is increasingly being pursued due to sustainability and ecological issues, and as a possible way to improve the therapeutic outcome of chronic skin diseases, relieving the burden for both patients and healthcare systems. The legalization of cannabis by a gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Ana M., Gomes, Ana L., Vilas Boas, Inês, Marto, Joana, Ribeiro, Helena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878527/
https://www.ncbi.nlm.nih.gov/pubmed/35215320
http://dx.doi.org/10.3390/ph15020210
_version_ 1784658681609060352
author Martins, Ana M.
Gomes, Ana L.
Vilas Boas, Inês
Marto, Joana
Ribeiro, Helena M.
author_facet Martins, Ana M.
Gomes, Ana L.
Vilas Boas, Inês
Marto, Joana
Ribeiro, Helena M.
author_sort Martins, Ana M.
collection PubMed
description The use of natural products in dermatology is increasingly being pursued due to sustainability and ecological issues, and as a possible way to improve the therapeutic outcome of chronic skin diseases, relieving the burden for both patients and healthcare systems. The legalization of cannabis by a growing number of countries has opened the way for researching the use of cannabinoids in therapeutic topical formulations. Cannabinoids are a diverse class of pharmacologically active compounds produced by Cannabis sativa (phytocannabinoids) and similar molecules (endocannabinoids, synthetic cannabinoids). Humans possess an endocannabinoid system involved in the regulation of several physiological processes, which includes naturally-produced endocannabinoids, and proteins involved in their transport, synthesis and degradation. The modulation of the endocannabinoid system is a promising therapeutic target for multiple diseases, including vascular, mental and neurodegenerative disorders. However, due to the complex nature of this system and its crosstalk with other biological systems, the development of novel target drugs is an ongoing challenging task. The discovery of a skin endocannabinoid system and its role in maintaining skin homeostasis, alongside the anti-inflammatory actions of cannabinoids, has raised interest in their use for the treatment of skin inflammatory diseases, which is the focus of this review. Oral treatments are only effective at high doses, having considerable adverse effects; thus, research into plant-based or synthetic cannabinoids that can be incorporated into high-quality, safe topical products for the treatment of inflammatory skin conditions is timely. Previous studies revealed that such products are usually well tolerated and showed promising results for example in the treatment of atopic dermatitis, psoriasis, and contact dermatitis. However, further controlled human clinical trials are needed to fully unravel the potential of these compounds, and the possible side effects associated with their topical use.
format Online
Article
Text
id pubmed-8878527
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88785272022-02-26 Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review Martins, Ana M. Gomes, Ana L. Vilas Boas, Inês Marto, Joana Ribeiro, Helena M. Pharmaceuticals (Basel) Review The use of natural products in dermatology is increasingly being pursued due to sustainability and ecological issues, and as a possible way to improve the therapeutic outcome of chronic skin diseases, relieving the burden for both patients and healthcare systems. The legalization of cannabis by a growing number of countries has opened the way for researching the use of cannabinoids in therapeutic topical formulations. Cannabinoids are a diverse class of pharmacologically active compounds produced by Cannabis sativa (phytocannabinoids) and similar molecules (endocannabinoids, synthetic cannabinoids). Humans possess an endocannabinoid system involved in the regulation of several physiological processes, which includes naturally-produced endocannabinoids, and proteins involved in their transport, synthesis and degradation. The modulation of the endocannabinoid system is a promising therapeutic target for multiple diseases, including vascular, mental and neurodegenerative disorders. However, due to the complex nature of this system and its crosstalk with other biological systems, the development of novel target drugs is an ongoing challenging task. The discovery of a skin endocannabinoid system and its role in maintaining skin homeostasis, alongside the anti-inflammatory actions of cannabinoids, has raised interest in their use for the treatment of skin inflammatory diseases, which is the focus of this review. Oral treatments are only effective at high doses, having considerable adverse effects; thus, research into plant-based or synthetic cannabinoids that can be incorporated into high-quality, safe topical products for the treatment of inflammatory skin conditions is timely. Previous studies revealed that such products are usually well tolerated and showed promising results for example in the treatment of atopic dermatitis, psoriasis, and contact dermatitis. However, further controlled human clinical trials are needed to fully unravel the potential of these compounds, and the possible side effects associated with their topical use. MDPI 2022-02-09 /pmc/articles/PMC8878527/ /pubmed/35215320 http://dx.doi.org/10.3390/ph15020210 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Martins, Ana M.
Gomes, Ana L.
Vilas Boas, Inês
Marto, Joana
Ribeiro, Helena M.
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_full Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_fullStr Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_full_unstemmed Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_short Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
title_sort cannabis-based products for the treatment of skin inflammatory diseases: a timely review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878527/
https://www.ncbi.nlm.nih.gov/pubmed/35215320
http://dx.doi.org/10.3390/ph15020210
work_keys_str_mv AT martinsanam cannabisbasedproductsforthetreatmentofskininflammatorydiseasesatimelyreview
AT gomesanal cannabisbasedproductsforthetreatmentofskininflammatorydiseasesatimelyreview
AT vilasboasines cannabisbasedproductsforthetreatmentofskininflammatorydiseasesatimelyreview
AT martojoana cannabisbasedproductsforthetreatmentofskininflammatorydiseasesatimelyreview
AT ribeirohelenam cannabisbasedproductsforthetreatmentofskininflammatorydiseasesatimelyreview